[LGND] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- 4.21%
YoY- 776.39%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 43,484 56,157 29,267 29,648 14,602 15,958 11,651 24.53%
PBT 842,713 55,312 6,193 9,571 -74 2,150 1,370 191.48%
Tax 176,376 10,033 1,114 3,694 15 53 66 272.29%
NP 666,337 45,279 5,079 6,608 754 2,097 1,495 176.25%
Tax Rate -20.93% -18.14% -17.99% -38.60% - -2.47% -4.82% -
Total Cost -622,853 10,878 24,188 23,040 13,848 13,861 10,156 -
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin 1,532.37 80.63 17.35 22.29 5.16 13.14 12.83 121.83%
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS 32.59 2.13 0.24 0.32 0.04 0.10 0.07 178.26%
EPS Diluted 31.32 1.83 0.22 0.30 0.04 0.10 0.07 176.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.